Growth BioPharma

Insatiable Appetite For Investment And Growth.

Transactions of unprecedented size and volume. Vital need and continuous drive to increase deal flow, scale and valuation. Locust Walk supports active, strategic asset acquisition and divestiture for companies in the growth-oriented biopharmaceutical sector.

Today’s environment presents unique opportunities and challenges for growth-oriented pharmaceutical companies. Over the past few years – fueled by an historically low cost of capital, opportunities for tax-advantaged foreign domiciles, and customer consolidation – a flurry of merger and acquisition activity has intensified into an accelerating stream of transactions.

Growth-oriented companies are often pursued as acquisition targets of other companies. Their best defense: Increasing scale and market valuation to stay beyond the reach of potential suitors and remain independent. For those that ultimately are acquired, bulking up can often increase deal value.

Locust Walk offers a unique blend of exclusivity, superior deal flow, depth of expertise, and breadth of service for the growth biopharma sector.

Our international team of seasoned industry executives delivers specific, relevant operating deal experience. We provide comprehensive and exclusive guidance and support on both the buy-side and the sell-side.

Buy-side Process

Sell-side Process

OVERVIEW

Asset criteria development
Opportunity screening
Profile development
Target outreach
Due diligence
Deal structuring and evaluation
Contract negotiations

RESULTS

Strategic fit
Non-obvious opportunities
Timely decision-making
Transactability
Immediate increase in shareholder value

OVERVIEW

Business case development
Targeted partner outreach
Due diligence staging
Deal structuring and evaluation
Contract negotiations

RESULTS

Data-driven approach
Structured process
Competitive tension and bidding
Real-time negotiations
Maximum deal value

Locust Walk offers a unique blend of exclusivity, superior deal flow, depth of expertise, and breadth of service for the growth biopharma sector.

Our international team of seasoned industry executives delivers specific, relevant operating deal experience. We provide comprehensive and exclusive guidance and support on both the buy-side and the sell-side.

Buy-side Process

OVERVIEW

Asset criteria development
Opportunity screening
Profile development
Target outreach
Due diligence
Deal structuring and evaluation
Contract negotiations

Buy-side Process

RESULTS

Strategic fit
Non-obvious opportunities
Timely decision-making
Transactability
Immediate increase in shareholder value

Sell-side Process

OVERVIEW

Business case development
Targeted partner outreach
Due diligence staging
Deal structuring and evaluation
Contract negotiations

Sell-side Process

RESULTS

Data-driven approach
Structured process
Competitive tension and bidding
Real-time negotiations
Maximum deal value

Locust Walk offers a unique blend of exclusivity, superior deal flow, depth of expertise, and breadth of service for the growth biopharma sector.

Our international team of seasoned industry executives delivers specific, relevant operating deal experience. We provide comprehensive and exclusive guidance and support on both the buy-side and the sell-side.